Drug intelligence / Profile preview

guizhiporing

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Guizhiporing (also known as Guizhi Poring pill) is a traditional Chinese medicine (TCM) preparation. It is used in TCM practice for conditions associated with kidney qi insufficiency, such as chronic prostatitis and related urinary symptoms. The formulation is typically prescribed to support kidney function and improve symptoms like urination difficulties and dizziness, especially when attributed to deficiencies in kidney qi according to TCM theory. The mechanism of action is based on the principles of TCM rather than modern pharmacology; it aims to tonify the kidneys, promote circulation of qi and blood, and address underlying imbalances that contribute to chronic urogenital disorders[2]. There are no established molecular targets or mechanisms recognized by Western medicine.

Other names: Guizhi Poring pill

Beyond the preview

Go deeper on guizhiporing.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on guizhiporing.

Explore the full profile